Stocksigma LogoStocksigma Logo

Saroja Pharma Approves FY26 Board Report and 8th AGM Notice

Saroja Pharma Industries India Limited's Board of Directors met on 7th Sep'26 and approved the Draft Board's Report and Management Discussion & Analysis

Saroja Pharma Approves FY26 Board Report and 8th AGM Notice

Saroja Pharma Industries India Ltd 路 Outcome 路 08 Sept 2026, 1:42 am

Saroja Pharma Approves FY26 Board Report and 8th AGM Notice Saroja Pharma Industries India Limited's Board of Directors met on 7th Sep'26 and approved the Draft Board's Report and Management Discussion & Analysis (MD&A) Report alongside their annexures for FY25-26, in compliance with the Companies Act, 2013, and SEBI (LODR) Regulations. Additionally, the board approved the draft notice convening the company's 8th Annual General Meeting (AGM) and finalized its scheduled date, time, and venue.

Original exchange filing (PDF)

More announcements from Saroja Pharma Industries India Ltd

All Saroja Pharma Industries India Ltd announcements